Vivani Medical, Inc. (VANI)
Oxford Ledge is still expanding full research coverage of VANI. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Vivani develops miniature, long-acting drug implants using NanoPortal technology to improve medication adherence in chronic disease treatment.
SEC filings
- 8-K Entry into material agreement; Other material event; Financial statements and exhibits 2026-07-07
- 8-K Departure/election of directors or officers; Shareholder vote results; Other material event; Financial statements and exhibits 2026-06-30
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-06-04
- 8-K Results of operations / financial condition; Regulation FD disclosure; Financial statements and exhibits 2026-05-13
- 10-Q Quarterly financial report (unaudited) 2026-05-13
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for VANI. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open VANI in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.